Hun Chuah

Transform-1: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, International Phase 3 Study of Navitoclax in Combination with Ruxolitinib Versus Ruxolitinib Plus Placebo in Patients with Untreated Myelofibrosis

Naveen Pemmaraju, Adam J. Mead, Tim C. P. Somervaille et al. · Blood · 2023 · 37 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +3

Blood use in patients receiving intensive chemotherapy for acute leukemia or hematopoietic stem cell transplantation: the impact of a health system–wide patient blood management program

Michael F. Leahy, Kevin M. Trentino, Colleen May et al. · Transfusion · 2017 · 33 citations

Medicine, Hematology, Chemotherapy +16

Imaging flow cytometry to assess chromosomal abnormalities in chronic lymphocytic leukaemia

Henry Hui, Kathryn A. Fuller, Hun Chuah et al. · Methods · 2017 · 29 citations

Medicine, Cell Biology, Hematology +16

Platelets in myeloproliferative neoplasms have a distinct transcript signature in the presence of marrow fibrosis

Belinda B. Guo, Matthew D. Linden, Kathryn A. Fuller et al. · British Journal of Haematology · 2019 · 25 citations · Full text

Medicine, Hematology, Pathology +14

Dual Targeting of Extramedullary Myeloma with Talquetamab and Teclistamab

Shaji Kumar, María-Victoria Mateos, Jing Christine Ye et al. · New England Journal of Medicine · 2025 · 23 citations

Medicine, Hematology, Pharmacology +17